Top Corner Capital

CND Life Sciences specializes in developing diagnostic tools for neurodegenerative diseases, particularly focusing on synucleinopathy. The company has introduced the Syn-One Test, which is designed to detect, visualize, and quantify abnormal phosphorylated alpha-synuclein in cutaneous nerve fibers. This commercially available test serves as an objective diagnostic aid for confirming synucleinopathy in patients suspected of having conditions such as Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, or pure autonomic failure. By providing a convenient and minimally invasive method for diagnosis, CND Life Sciences enhances the ability of medical professionals to accurately identify these complex disorders.

Longbow's SaaS platform enables companies to identify the Best Next Actions to reduce the most application and cloud risk.

Ugami is a developer of a financial mobile application that offers financial rewards services tailored for gamers. The platform allows users to earn points through gameplay, which can be redeemed for various rewards such as gaming merchandise, digital goods, and exclusive access to esports events. Additionally, Ugami facilitates virtual card purchases via debit and credit cards, enabling users to accumulate points while managing their finances effectively. By integrating gaming with personal finance education, Ugami aims to enhance the gaming experience while promoting financial literacy among its users.